Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Interest Income Expense
Zymeworks Inc
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Interest Income Expense
$18.5m
|
CAGR 3-Years
36%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Interest Income Expense
-$8.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Interest Income Expense
$13.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Interest Income Expense
$4.1m
|
CAGR 3-Years
131%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Interest Income Expense
$13.7m
|
CAGR 3-Years
157%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
34%
|
|
Spectral Medical Inc
TSX:EDT
|
Interest Income Expense
-CA$3.2m
|
CAGR 3-Years
-373%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Zymeworks Inc's Interest Income Expense?
Interest Income Expense
18.5m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Interest Income Expense amounts to 18.5m USD.
What is Zymeworks Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
47%
Over the last year, the Interest Income Expense growth was 294%. The average annual Interest Income Expense growth rates for Zymeworks Inc have been 36% over the past three years , 47% over the past five years .